Fecal Transplants Show Promise for Colitis, MS, Depression and Even Alcohol Cravings
Randomized trials and case reports reveal stool transplants may treat conditions far beyond gut disease — including mental health and addiction.
Summary
Fecal microbiota transplantation (FMT) is moving well beyond treating gut infections. This NutritionFacts.org video reviews randomized controlled trials and case reports examining FMT for ulcerative colitis, multiple sclerosis, depression, bipolar disorder, and alcoholism. The most striking finding involves alcohol cravings — suggesting the gut microbiome may directly influence addictive behavior through the gut-brain axis. Dr. Greger also points viewers toward diet-based alternatives for improving microbiome health, including prebiotic foods and fiber-rich eating patterns. While FMT remains experimental for most of these conditions, the evidence signals that the microbiome plays a broader role in systemic and neurological health than previously understood. For those not ready for 'brown smoothies,' dietary strategies remain the most accessible starting point.
Detailed Summary
The gut microbiome is emerging as a powerful regulator of health far beyond digestion, and fecal microbiota transplantation (FMT) is one of the most direct ways researchers are testing that hypothesis. This video from Dr. Michael Greger reviews clinical evidence — including randomized controlled trials and case reports — for FMT across a surprisingly wide range of conditions: ulcerative colitis, multiple sclerosis, depression, bipolar disorder, and alcoholism.
For ulcerative colitis, FMT has the strongest clinical backing among the conditions reviewed, with randomized trials showing meaningful remission rates when donor stool is transferred to patients with active disease. The gut-immune connection makes this a logical target, as colitis involves dysregulated immune responses in the intestinal lining.
Perhaps the most compelling and unexpected findings involve neurological and psychiatric conditions. Case reports and early trials suggest FMT may influence MS progression, mood disorders like depression and bipolar disorder, and — most strikingly — alcohol cravings. This points to the gut-brain axis as a genuine therapeutic pathway, where microbial composition shapes neurotransmitter signaling, inflammation, and even behavioral drives like addiction.
These findings carry real implications for longevity research. Chronic inflammation, neurodegeneration, and metabolic dysfunction — all influenced by microbiome composition — are central drivers of aging and age-related disease. Interventions that restore a healthy microbiome could theoretically address multiple hallmarks of aging simultaneously.
Important caveats apply: many findings outside ulcerative colitis come from case reports rather than large randomized trials, meaning they are hypothesis-generating rather than conclusive. Dr. Greger also highlights diet-based microbiome optimization — prebiotics and diverse plant foods — as a practical, accessible alternative to clinical FMT for most people. Consulting a gastroenterologist before pursuing FMT is essential.
Key Findings
- FMT shows strongest randomized trial evidence for inducing remission in ulcerative colitis patients.
- Case reports suggest FMT may reduce alcohol cravings, implicating the gut-brain axis in addiction.
- Early evidence links microbiome transplantation to potential benefits in MS and mood disorders.
- Diet-based strategies — prebiotic and fiber-rich foods — can improve microbiome without clinical FMT.
- Gut microbiome health is increasingly linked to systemic inflammation and neurological function relevant to aging.
Methodology
This is a 'Friday Favorites' episode from NutritionFacts.org, a nonprofit evidence-based nutrition platform run by Dr. Michael Greger, MD FACLM. The video synthesizes randomized controlled trials and case reports across multiple conditions. The channel is well-regarded for citing primary literature, though its plant-based advocacy lens should be noted.
Study Limitations
This summary is based on the video description only, not the full spoken content or cited studies — specific trial names, effect sizes, and patient populations could not be verified. Case report findings for MS, depression, bipolar, and alcoholism should be treated as preliminary until confirmed by larger randomized trials. Viewers should consult primary sources linked on the NutritionFacts.org video page for full citations.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.
Enter your email to subscribe: